15+1 EU Priority PAHs
Column: DB-EUPAH 121-9627 20 m x 0.18 mm, 0.14 µm
Carrier: Inlet:
Oven:
Instrument: Agilent 6890N/5975B MSD Sampler: Agilent 7683B, 5.0 µL syringe (Agilent p/n 5181-1273) 0.5 µL splitless injection, injection speed 75 µL/min
Detector: MSD source at 300°C, quadrupole at 180°C, transfer line at 330°C, Scan range 50-550 AMU
45°C (0.8 min) to 200°C (45°C/min), 2.5°C/min to 225°C, 3°C/min to 266°C, 5°C/min to 300°C, 10°C/min to 320°C (4.5 min)
325°C splitless, purge flow 60 mL/min at 0.8 min Resolution of Critical Pairs on an Agilent J&WDB-EUPAH Column
10000 11000 12000 13000 14000
1000 2000 3000 4000 5000 6000 7000 8000 9000
0 10.00 15.00 20.00 25.00 Time 30.00 35.00 40.00 EU_PAHs 1 Rs 2.4 Rs 2.7 4 Rs 1.7 2 3 5 6 7 8 9 Rs 1.6 Rs 2.6 12 10 11 13 14 16 15
1. Benzo[c]fluorene 2. Benz[a]anthracene 3. Cyclopenta[c,d]pyrene 4. Chrysene 5. 5-Methylchrysene 6. Benzo[b]fluoranthene 7. Benzo[k]fluoranthene 8. Benzo[j]fluoranthene 9. Benz[a]pyrene 10. Indeno[1,2,3-cd]pyrene 11. Dibenzo[a,h]anthracene 12. Benzo[g,h,i]perylene 13. Dibenzo[a,l]pyrene 14. Dibenzo[a,e]pyrene 15. Dibenzo[a,i]pyrene 16. Dibenzo[a,h]pyrene
Suggested Supplies Septum: 11 mm Advanced Green septa, 5183-4759 Liner: Direct connect, dual taper, deactivated, 4 mm ID, G1544-80700
Syringe: 5 µL tapered, FN 23-26s/42/HP, 5181-1273
Helium, ramped flow 1.0 mL/min (0.2 min), 5 mL/min2 to 1.7 mL/min
All 15+1 EU regulated priority PAHs are well resolved with the DB-EUPAH column. Challenging Benzo(b,k,j)fluoranthene isomers are baseline resolved, allowing for accurate quantitation of each isomer. In addition, baseline resolution is achieved for critical pairs benz[a]anthracene and cyclopenta[c,d]pyrene, cyclopenta[c,d]pyrene and chrysene, and indeno[1,2,3-cd]pyrene and dibenz[a,h]anthracene. This application demonstrates that the DB-EUPAH column can provide excellent sensitivity and selectivity for the analysis of EU regulated PAHs.
42
Order online at
www.agilent.com/chem/store
Abundance
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148 |
Page 149 |
Page 150 |
Page 151 |
Page 152 |
Page 153 |
Page 154 |
Page 155 |
Page 156 |
Page 157 |
Page 158 |
Page 159 |
Page 160 |
Page 161 |
Page 162 |
Page 163 |
Page 164 |
Page 165 |
Page 166 |
Page 167 |
Page 168